<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.atherosclerosis.2020.10.897</dc:identifier><dc:language>eng</dc:language><dc:creator>Lamiquiz-Moneo, I.</dc:creator><dc:creator>Mateo-Gallego, R.</dc:creator><dc:creator>Fernández-Pardo, J.</dc:creator><dc:creator>López-Ariño, C.</dc:creator><dc:creator>Marco-Benedí, V.</dc:creator><dc:creator>Bea, A.M.</dc:creator><dc:creator>Ferraro, L.</dc:creator><dc:creator>Jarauta, E.</dc:creator><dc:creator>Cenarro, A.</dc:creator><dc:creator>Civeira, F.</dc:creator><dc:title>Glycerol kinase deficiency in adults: Description of 4 novel cases, systematic review and development of a clinical diagnostic score</dc:title><dc:identifier>ART-2020-121242</dc:identifier><dc:description>Background and aims: Glycerol kinase deficiency (GKD) is a rare genetic disorder characterized by hyperglycerolemia and glyceroluria, which could be misdiagnosed as a moderate to severe hypertriglyceridemia (HTG). We aimed to describe four novel cases of GKD, to complete a systematic review of all cases of isolated GKD published so far, and to develop a suspicion clinical diagnostic score for GKD. 
Methods: We reported four cases with suspicion of GKD and compared their phenotype with 584 males with triglycerides (TG) &gt; 300 mg/dL, selected as control group (HTG non-GKD). The GK gene was sequenced in all cases. Lipoprotein particle concentrations were measured in all cases with GKD. The systematic review involved a PubMed, Cochrane and Scopus databases search to identify anthropometric and biochemical characteristics of all described cases with GKD. 
Results: The systematic review retrieved a total of 15 articles involving 39 subjects with GKD. GKD cases reported a history of high TG levels resistant to lipid-lowering therapy. Compared to GKD subjects (n = 43), HTG non-GKD subjects (n = 584) showed significantly higher BMI, total cholesterol, non-HDL cholesterol and gamma-glutamyltransferase, significantly lower HDL cholesterol and TG, and higher prevalence of diabetes. The proposed diagnostic score was significantly higher in GKD than in HTG non-GKD subjects. 
Conclusions: This is the first systematic review that compiles all GKD cases reported to date including 4 novel cases, and examine the differential GKD phenotype compared to other types of HTG. The proposed score would have a broad utility in clinical practice to avoid unwarranted lipid lowering treatment in GKD patients.</dc:description><dc:date>2020</dc:date><dc:source>http://zaguan.unizar.es/record/121834</dc:source><dc:doi>10.1016/j.atherosclerosis.2020.10.897</dc:doi><dc:identifier>http://zaguan.unizar.es/record/121834</dc:identifier><dc:identifier>oai:zaguan.unizar.es:121834</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B14-7R</dc:relation><dc:relation>info:eu-repo/grantAgreement/EUR/ISCII-ERDF/A way to make Europe</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/CIBERCV</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/PI15-01983</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/PI18-01777</dc:relation><dc:identifier.citation>Atherosclerosis 315 (2020), 24-32</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>